PerkinElmer's Q2 Revenues Rise 3 Percent | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer said after the stock market closed on Thursday that its second quarter revenues grew 3 percent year over year.

The Waltham, Mass.-based company said that for the three months ended June 29, revenues were up to $556.2 million from $540.7 million in the year-ago quarter and fell short of the consensus Wall Street estimate of $571.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.